The report is available in English with a French summary - KCE

92 Musculoskeletal & Neurological Rehabilitation KCE reports 57
Figure 5.25: Expenditures evolution of the K-nomenclature in Euro (2000-
2004)
S
o
u
r
c
e
:
60.000.000
R
I 55.000.000
Z
I 50.000.000
V
/ 45.000.000
I
40.000.000
N
A 35.000.000
M
I 30.000.000
2
0
06
65.000.000
Figure 5.26: Detailed overview expenditures growth K-nomenclature (2000-
2004)
12.000.000
10.000.000
8.000.000
6.000.000
4.000.000
2.000.000
0
-2.000.000
Source: RIZIV/INAMI 2006
€
€
2000 2001 2002 2003 2004
K-30 A K-30 H K-60 A K-60 H
Because K30 and K60 treatments sessions are the only longitudinally comparable data,
and since multidisciplinary therapy is the focus of this study, we excluded all other
treatments from this graph.
K60 accounts for the largest part of the growth in expenditures (€) and has no negative
growth during the period under review. The expenditures for K30 increased in the
period 2001 – 2004 with a negative growth in 2004 as well for ambulatory care out
patients) as hospitalized patients (in patients).
As mentioned in 5.1.7.2, the Technical Medical Board proposed a measure in order to
control this grow’th in K60 expenditures by replacing K60 for code 402A, which is the
2004
2003
2002
2001